{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:45:25Z","timestamp":1759229125310,"version":"3.41.2"},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI17C2196"],"award-info":[{"award-number":["HI17C2196"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI19C0027"],"award-info":[{"award-number":["HI19C0027"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Res &amp; Perspec"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report a phase I pharmacological study of an oral formulation of CKD\u2010516, a vascular\u2010disrupting agent, in patients with refractory solid tumors. Twenty\u2010seven patients (16 in the dose\u2010escalation cohort and 11 in the expansion cohort) received a single daily dose (5\u201025\u00a0mg) of CKD\u2010516 five days per week. Nausea (67%) and diarrhea (63%) were the most common treatment\u2010related adverse events. The recommended phase II dose of oral CKD\u2010516 was 20\u00a0mg\/d (15\u00a0mg\/d with a body surface area (BSA) &lt;1.65\u00a0m<jats:sup>2<\/jats:sup>). Notably, S\u2010516 half\u2010lives in patients receiving 15\u201020\u00a0mg CKD\u2010516\/d significantly differed between patients with and without splenomegaly that is suggestive of portal hypertension associated with liver cirrhosis (6.1 vs 4.6\u00a0hours, respectively). Of 11 patients without splenomegaly who completed at least one cycle of a daily CKD\u2010516 dose of either 15 or 20\u00a0mg, only one patient (9.1%) suffered from any dose\u2010limiting toxicity. We conclude that a daily oral dose of 15 or 20\u00a0mg CKD\u2010516 five days per week could be tolerable in patients without liver cirrhosis.<\/jats:p>","DOI":"10.1002\/prp2.568","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T09:50:20Z","timestamp":1584006620000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phase I and pharmacokinetic study of the vascular\u2010disrupting agent CKD\u2010516 (NOV120401) in patients with refractory solid tumors"],"prefix":"10.1002","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9814-1829","authenticated-orcid":false,"given":"Hark Kyun","family":"Kim","sequence":"first","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Won","family":"Kang","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young\u2010Whan","family":"Park","sequence":"additional","affiliation":[{"name":"National Oncoventure National Cancer Center Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Young","family":"Kim","sequence":"additional","affiliation":[{"name":"National Oncoventure National Cancer Center Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minchae","family":"Kim","sequence":"additional","affiliation":[{"name":"National Oncoventure National Cancer Center Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"CKD Research Center Yongin\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se\u2010mi","family":"Kim","sequence":"additional","affiliation":[{"name":"CKD Research Center Yongin\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun","family":"Ho Ryu","sequence":"additional","affiliation":[{"name":"CKD Research Center Yongin\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonghae","family":"Yoon","sequence":"additional","affiliation":[{"name":"Clinical Trials Center Seoul National University Bundang Hospital Bundang\u2010gu Seongnam\u2010si Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-7351","authenticated-orcid":false,"given":"Yun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo\u2010Youn","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun Seok","family":"Lee","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tak","family":"Yun","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiwon","family":"Kim","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Hyang","family":"Kwak","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae\u2010Sung","family":"Kim","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsoo","family":"Chung","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong\u2010Won","family":"Park","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital Goyang\u2010si Gyeonggi\u2010do Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150114163732"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990233"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2016.08.007"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0427"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.137"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2414"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm1002414"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.05.060"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-013-0043-8"},{"key":"e_1_2_10_11_1","first-page":"1715","article-title":"Enhanced efficacy of CKD\u2010516 in combination with doxorubicin: pre\u2010clinical evaluation using a hepatocellular carcinoma xenograft model","volume":"34","author":"Kim YI","year":"2014","journal-title":"Anticancer Res"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2014.258"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057307"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40661-017-0058-5"}],"container-title":["Pharmacology Research &amp; Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fprp2.568","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.568","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/prp2.568","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T06:43:16Z","timestamp":1694068996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/prp2.568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1002\/prp2.568"],"URL":"https:\/\/doi.org\/10.1002\/prp2.568","archive":["Portico"],"relation":{},"ISSN":["2052-1707","2052-1707"],"issn-type":[{"type":"print","value":"2052-1707"},{"type":"electronic","value":"2052-1707"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"2019-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00568"}}